New Delhi: The decline in the effectiveness of Covaxin, India’s indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists. The differing figures led to some concern, particularly among those who had received Covaxin, but several scientists […]
